Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maura Brunetti

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
Neurology|October 27, 2020
Differential Neuropsychological Profile of Patients With Amyotrophic Lateral Sclerosis With and Without <i>C9orf72</i> MutationBarbara Iazzolino, Laura Peotta, Jean Pierre Zucchetti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 10, 2019
Analysis of the GCG repeat length in NIPA1 gene in C9orf72-mediated ALS in a large Italian ALS cohortLucia Corrado, Maura Brunetti, Alice Di Pierro, et al.
Neurology|October 27, 2012
Extensive genetics of ALS: a population-based study in ItalyAdriano Chiò, Andrea Calvo, Letizia Mazzini, et al.
Clinical Colorectal Cancer|September 10, 2011
Outcome of second-line treatment after first-line chemotherapy with the GONO FOLFOXIRI regimenLorenzo Fornaro, Enrico Vasile, Gianluca Masi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 22, 2014
The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patientsAngelina Cistaro, Marco Pagani, Anna Montuschi, et al.
Annals of Surgery|February 28, 2009
Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastasesGianluca Masi, Fotios Loupakis, Luca Pollina, et al.
Neurobiology of Aging|May 20, 2009
Two Italian kindreds with familial amyotrophic lateral sclerosis due to FUS mutationAdriano Chiò, Gabriella Restagno, Maura Brunetti, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 25, 2019
Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: a population-based studyUmberto Manera, Andrea Calvo, Margherita Daviddi, et al.
Archives of Neurology|August 11, 2010
Amyotrophic lateral sclerosis-frontotemporal lobar dementia in 3 families with p.Ala382Thr TARDBP mutationsAdriano Chiò, Andrea Calvo, Cristina Moglia, et al.
Neurobiology of Aging|September 22, 2018
A novel p.Ser108LeufsTer15 SOD1 mutation leading to the formation of a premature stop codon in an apparently sporadic ALS patient: insights into the underlying pathomechanismsAntonio Canosa, Giovanni De Marco, Annarosa Lomartire, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Neurology|October 27, 2020
Differential Neuropsychological Profile of Patients With Amyotrophic Lateral Sclerosis With and Without <i>C9orf72</i> MutationBarbara Iazzolino, Laura Peotta, Jean Pierre Zucchetti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 10, 2019
Analysis of the GCG repeat length in NIPA1 gene in C9orf72-mediated ALS in a large Italian ALS cohortLucia Corrado, Maura Brunetti, Alice Di Pierro, et al.
Neurology|October 27, 2012
Extensive genetics of ALS: a population-based study in ItalyAdriano Chiò, Andrea Calvo, Letizia Mazzini, et al.
Clinical Colorectal Cancer|September 10, 2011
Outcome of second-line treatment after first-line chemotherapy with the GONO FOLFOXIRI regimenLorenzo Fornaro, Enrico Vasile, Gianluca Masi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 22, 2014
The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patientsAngelina Cistaro, Marco Pagani, Anna Montuschi, et al.
Annals of Surgery|February 28, 2009
Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastasesGianluca Masi, Fotios Loupakis, Luca Pollina, et al.
Neurobiology of Aging|May 20, 2009
Two Italian kindreds with familial amyotrophic lateral sclerosis due to FUS mutationAdriano Chiò, Gabriella Restagno, Maura Brunetti, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 25, 2019
Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: a population-based studyUmberto Manera, Andrea Calvo, Margherita Daviddi, et al.
Archives of Neurology|August 11, 2010
Amyotrophic lateral sclerosis-frontotemporal lobar dementia in 3 families with p.Ala382Thr TARDBP mutationsAdriano Chiò, Andrea Calvo, Cristina Moglia, et al.
Neurobiology of Aging|September 22, 2018
A novel p.Ser108LeufsTer15 SOD1 mutation leading to the formation of a premature stop codon in an apparently sporadic ALS patient: insights into the underlying pathomechanismsAntonio Canosa, Giovanni De Marco, Annarosa Lomartire, et al.
Pageof 9